Combines BioSkryb’s new ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit 384-well assay with Uno Single Cell Dispenser™ provided by Tecan in a single workflow Enables scalable, high-throughput analysis of hundreds to thousands of single cells, advancing applications in cancer research, drug development and precision medicine Durham, NC and Männedorf, Switzerland – BioSkryb Genomics and Tecan […]
Combines BioSkyrb’s new ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit 384-well assay with Uno Single Cell Dispenser™ provided by Tecan in a single workflow Enables scalable, high-throughput analysis of hundreds to thousands of single cells, advancing applications in cancer research, drug development and precision medicine Durham, NC and Männedorf, Switzerland – BioSkryb Genomics and Tecan […]
Investment demonstrates confidence in America’s commitment to science and innovation WALTHAM, Mass. — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, will invest an additional $2 billion in the United States over the next four years, strengthening American innovation, manufacturing and economic competitiveness across the life sciences sector. As one of […]
FOSTER CITY, Calif. and DURHAM, N.C. — 1Cell.Ai, a global leader in single cell precision diagnostics, has joined forces with BioSkryb Genomics, a pioneer in single cell multi-omics, to co-develop and commercialize next-generation single cell multi-omic solutions. This collaboration will empower researchers and clinicians to detect and characterize rare mutations in single cells with unprecedented accuracy, facilitating breakthroughs in cancer […]
Adds to robust offering of NGS tools enabling exome sequencing, whole genome sequencing, RNA sequencing, deep sequencing for liquid biopsy research and MRD, and methylation detection Diverse portfolio of adapter sets now includes industry leading number of unique indexes at 3,072 HT UDI Adapters Enables multiplexing and high throughput sequencing SOUTH SAN FRANCISCO, Calif. — […]
Boulder, CO – Watchmaker Genomics, a leader in high-performance genomics solutions, today announced an important milestone in providing comprehensive and robust automated solutions for next-generation sequencing (NGS) workflows. Its collaboration with Revvity has resulted in fully automated and verified methods for all of its DNA and RNA library preparation kits on the Sciclone™ G3 NGSx* liquid […]
SINGAPORE — GenScript Biotech Corporation, a global leader in biotechnology research services, and NSG Bio, Singapore’s premier biotech incubator, today announced a strategic partnership designed to accelerate innovation and growth within the biotechnology sector. Through this partnership, GenScript will provide exclusive preferential rates along with technical guidance from experienced scientists across its extensive range of biotechnology services and […]
SCOTTS VALLEY, Calif. — Dovetail Genomics, a leading innovator in genomic solutions, today announced an expanded comprehensive analysis solution for somatic variation detection, addressing the challenge of identifying structural variants (SVs) using NGS platforms. The solution offers ultra-sensitive discovery of SVs at base-pair resolution down to 1% variant allele frequency (VAF), and biologically meaningful interpretation of SVs […]
Joint grant program will provide researchers focused on emerging areas of oncology with powerful multi-omic platforms to drive new discoveries DURHAM, N.C. & FREMONT, Calif. — BioSkryb Genomics, a pioneer in single-cell and ultra–low-input multi-omic solutions, and Ultima Genomics, a leader in scalable and cost-effective sequencing, today announced a collaboration designed to accelerate next-generation oncology research. […]
Forms Special Committee of the Board to Lead Evaluation of Viable Options for Maximizing Shareholder Value Engages Independent Financial and Legal Advisors to Support Thorough Process Remains Committed to Maintaining Focus on Cost Containment, Cash Preservation and Near-Term Initiatives to Enhance Value Farmingdale, NY — Enzo Biochem, Inc. (OTCQX: ENZB) (“Enzo” or the “Company”) today […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
